PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026World Journal of Gastrointestinal Oncology0 citationsOpen Access

Clinical efficacy of Fuzheng Jiedu Xiaoyong granules in advanced colorectal cancer (spleen deficiency and stasis toxin syndrome)

View Full Paper
HQHai-Yun QinLiaoning University of Traditional Chinese MedicineZLZheng LiHealth and Family Planning Commission of Sichuan ProvincePCPei-Wei CongLiaoning University of Traditional Chinese Medicine

Key Points

  • Fuzheng Jiedu Xiaoyong granules effectively reduce chemotherapy-induced toxicities and enhance immune function.
  • Clinically, these granules alleviate symptoms in patients suffering from advanced colorectal cancer and spleen deficiency.

Structured PICO

Does Fuzheng Jiedu Xiaoyong granules improve clinical symptoms, enhance immune function, and reduce chemotherapy-induced toxicities in patients with advanced colorectal cancer with spleen deficiency and stasis toxin syndrome?

P
Population
Patients with advanced colorectal cancer (CRC) with spleen deficiency and stasis toxin syndrome
I
Intervention
Fuzheng Jiedu Xiaoyong granules (FZJDXYG)
O
Outcome
Clinical symptoms, immune function, and chemotherapy-induced toxicities

Fuzheng Jiedu Xiaoyong granules may improve symptoms, enhance immune function, and reduce chemotherapy toxicity in advanced colorectal cancer patients with specific traditional Chinese medicine syndromes.

Abstract

FZJDXYG effectively ameliorates clinical symptoms, enhances immune function, and reduces chemotherapy-induced toxicities in patients with advanced CRC with spleen deficiency and stasis toxin syndrome.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Qin et al. (2026) studied this question.

synapsesocial.com/papers/69a7657ebadf0bb9e87d94c8https://doi.org/10.4251/wjgo.v18.i2.113922
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries2021 · 114,179 citations
  2. 2New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)2008 · 30,019 citations
  3. 3A comprehensive review of antitumor properties of Angelica species and their antitumor‐responsible constituents and the underlying molecular mechanisms involved in tumor inhibition2023 · 23 citations
  4. 4Systematic elucidation of the effective constituents and potential mechanisms of Scrophulariae Radix against neoplasm based on LC-MS, network pharmacology, and molecular docking approaches2025 · 4 citations
  5. 5CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas2020 · 894 citations